Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104846) titled 'Clinical comparative study of Lashunadi Vati and Tiladi Vati on Polycystic Ovarian Syndrome' on Feb. 26.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Coin toss, Lottery, toss of dice, shuffling cards etc Method of allocation concealment:Case Record Numbers Blinding and masking:Open Label
Primary Sponsor: Dr Priyanka Dattatraya Nikam
Condition:
Health Condition 1: N926- Irregular menstruation, unspecified
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 15-03-2026
Target Sample Size: 90
Countries ...